Skip to main content
Clinical Trials/NCT06453148
NCT06453148
Not Yet Recruiting
N/A

Prospective Clinical Registry of Heart Transplant Patients in Brazil

Hospital Israelita Albert Einstein1 site in 1 country730 target enrollmentAugust 25, 2024

Overview

Phase
N/A
Intervention
Not specified
Conditions
Heart Transplant Failure and Rejection
Sponsor
Hospital Israelita Albert Einstein
Enrollment
730
Locations
1
Primary Endpoint
Combined of total hospitalizations and all-causes deaths
Status
Not Yet Recruiting
Last Updated
last year

Overview

Brief Summary

Prospective cohort clinical study, registry-based, multicenter, national, with the consecutive inclusion of patients with a history of Heart Transplantation in Brazil. The clinical registry will involve the participation until 25 centers. Patients will be included up to 30 days after Heart Transplant surgery and will be followed for one year. Laboratory tests and clinical parameters wil be collected in two clinical visits (6mo and 12 mo). The outcomes evaluate will be the total hospitalizations and all-cause death. It is expected to include 730 patients with a 12-month follow-up from the day of the transplant surgery. The findings of the HESTIA Registry may guide the management of post-heart transplant patients, aiming at reducing morbidity and mortality within 12 months after heart transplant surgery.

Detailed Description

The study will include participants who have undergone heart transplantation at transplant centers across Brazil. Patients will be enrolled within the first 30 days after surgery and will be followed for one year. The study will be participant-centered through clinical visits. There will be an admission visit and two additional visits: one at 6 months (V1) and another at 12 months (V2), which will be the closing visit

Registry
clinicaltrials.gov
Start Date
August 25, 2024
End Date
August 25, 2027
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients over 18 years old;
  • Heart Transplantation within 30 days of both sexes;

Exclusion Criteria

  • Refusal to provide consent for the study;
  • In the judgment of the local investigator, any difficulty accessing follow-up visits

Outcomes

Primary Outcomes

Combined of total hospitalizations and all-causes deaths

Time Frame: 12 months

Incidence of Hospitalization and death

Secondary Outcomes

  • Incidence of organ rejection;(12 months)
  • Incidence of hospitalizations due to infections not related to the primary outcome;(12 months)
  • Cardiovascular mortality; Cardiovascular mortality(12 months)
  • Individual components of the primary outcome;(12 months)
  • Vaccination rate;(12 months)

Study Sites (1)

Loading locations...

Similar Trials